Page last updated: 2024-12-05

anethole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth

Description

anethole: an isomer of estragole; structurally similar to CAPSAICIN; has some neurological and insecticidal and skin absorption effects; RN given refers to unspecified stereoisomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

anethole : A monomethoxybenzene that is methoxybenzene substituted by a prop-1-en-1-yl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

trans-anethole : The trans-stereoisomer of anethole. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID637563
CHEMBL ID452630
CHEBI ID35616
SCHEMBL ID48599
MeSH IDM0049202

Synonyms (182)

Synonym
LS-13792
AB00053256-02
4-methoxy-1-propenylbenzene
anisole, p-propenyl-
4-methoxypropenylbenzene
wln: 2u1r do1
propene, 1-(p-methoxyphenyl)-
4-propenylanisole
1-methoxy-4-(1-propenyl)benzene
nsc4018
1-methoxy-4-propenylbenzene
benzene, 1-methoxy-4-(1-propenyl)-
p-1-propenylanisole
1-propene, 1-(4-methoxyphenyl)-
p-methoxy-.beta.-methylstyrene
104-46-1
aniskampfer
p-propenylphenyl methyl ether
p-propenylanisole
nsc-4018
anise camphor
anethol
isoestragole
(e)-anethol
cis-anethol
BSPBIO_002818
CHEBI:35616 ,
SPECTRUM5_000727
monasirup
nsc 209529
benzene, 1-methoxy-4-(1e)-1-propenyl-
(e)-1-methoxy-4-(1-propenyl)benzene
(e)-p-propenylanisole
methoxy-beta-methylstyrene, trans-p-
einecs 224-052-0
ccris 2481
(e)-1-(4-methoxyphenyl)propene
fema no. 2086
trans-p-methoxy-beta-methylstyrene
1-methoxy-4-[(1e)-prop-1-en-1-yl]benzene
1-p-methoxyphenylpropene, trans-
propenylanisole, p-, (e)-
anisole, p-propenyl-, (e)-
brn 0636190
trans-4-(1-propenyl)anisole
(e)-anethole
anisole, p-propenyl-, trans-
benzene, 1-methoxy-4-(1-propenyl)-, (e)-
anethole, trans-
1-methoxy-4-(1-propenyl)benzene, (e)-
trans-1-p-anisylpropene
trans-anethole (natural)
4180-23-8
trans-p-methoxy-.beta.-methylstyrene
wln: 2u1r do1 -t
nsc209529
trans-p-propenylanisole
p-anethole
anisole, trans-
trans-anethol
nsc-209529
ai3-00380
anethol (synthetic)
p-methoxy-beta-methylstyrene
hsdb 1427
nsc 4018
fema number 2086
brn 0774229
caswell no. 051b
acintene o
einecs 203-205-5
epa pesticide chemical code 015604
ccris 6211
p-propenylmethoxybenzene
anethole
trans-anethole
t-anethole
benzene,1-methoxy,4-propenyl(trans) trans anethol
GHL.PD_MITSCHER_LEG0.12
inchi=1/c10h12o/c1-3-4-9-5-7-10(11-2)8-6-9/h3-8h,1-2h3/b4-3
trans-anethole, >=99%, fcc, fg
D02377
anethole (nf)
trans-anethole, 99%
NCGC00091493-03
NCGC00091493-02
SPECTRUM1503705
NCGC00091493-04
HMS2093I09
HMS2089P20
anethole (natural)
anethole, trans
CHEMBL452630
P0494
trans-p-methoxypropenylbenzene
HMS1922I20
STK801277
1-methoxy-4-[(e)-prop-1-enyl]benzene
AKOS000121299
NCGC00091493-07
NCGC00091493-05
NCGC00091493-06
unii-a79c64yd3q
2-06-00-00523 (beilstein handbook reference)
a79c64yd3q ,
benzene, 1-methoxy-4-(1-propen-1-yl)-
NCGC00259831-01
dtxcid2087
tox21_300132
cas-4180-23-8
NCGC00259550-01
NCGC00254015-01
tox21_202001
tox21_202282
dtxsid9020087 ,
nsc-758626
nsc758626
pharmakon1600-01503705
tox21_111139
cas-104-46-1
dtxcid0086
(e)-1-methoxy-4-(prop-1-en-1-yl)benzene
benzene, 1-methoxy-4-(propenyl)-
einecs 256-753-2
benzene, 1-methoxy-4-(propen-1-yl)-
S3779
CCG-38720
q3jek5do4k ,
unii-q3jek5do4k
ec 224-052-0
benzene, 1-methoxy-4-(1e)-1-propen-1-yl-
anethole [nf]
anethole [fcc]
anethole [who-dd]
anethole [ii]
anethole [usp-rs]
1-methoxy-4-(1e)-1-propen-1-ylbenzene
anethole, (e)-
(e)-anethole (constituent of myrrh) [dsc]
anethole [vandf]
anethole [mi]
anethole [inci]
trans-anethole [fhfi]
BRD-K49060658-001-01-5
SCHEMBL48599
BBL027751
tox21_111139_1
NCGC00091493-09
1-methoxy-4-(prop-1-en-1-yl)benzene
methyl 4-(prop-1-en-1-yl)phenyl ether
RUVINXPYWBROJD-ONEGZZNKSA-N
Q-201853
DS-2756
AC-34207
W-108812
HY-B0900
AB00053256_03
(e)?-anethole
sr-05000001866
SR-05000001866-2
anethole, united states pharmacopeia (usp) reference standard
trans-anethole, analytical standard
trans-anethole, purum, >=98.0% (gc)
trans-anethole, primary pharmaceutical reference standard
SR-05000001866-1
anethol, natural, 99%, fg
trans-anethole, pharmaceutical secondary standard; certified reference material
SBI-0052758.P002
(e)-1-methoxy-4-(prop-1-enyl)benzene
Q255564
A14711
EN300-18430
HMS3885E16
trans-anethole ((e)-anethole)
D70168
A873002
4-trans-propenyl-anisole
S3990
|trans|-anethole
26795-32-4
EN300-1695718
Z2315575049

Research Excerpts

Toxicity

The pattern of species, sex and dose dependency strongly suggests that metabolic and pharmacokinetic studies will be helpful in interpreting the significance of the rat tumours with regard to the safe consumption of trans-anethole by man.

ExcerptReferenceRelevance
" This pattern of species, sex and dose dependency strongly suggests that metabolic and pharmacokinetic studies will be helpful in interpreting the significance of the rat tumours with regard to the safe consumption of trans-anethole by man."( Chronic toxicity/carcinogenicity study of trans-anethole in rats.
Attia, M; Caldwell, J; Glomot, R; Le Bourhis, B; Newman, J; Truhaut, R, 1989
)
0.28
" Considering the trans-anethole genotoxicity data base as a whole, including the positive response observed only in the L5178Y mouse lymphoma TK+/- assay, the irreproducible response in the Salmonella/microsome test, the negative result in the chromosome aberration test in vitro and the results from 32P-postlabeling studies in vivo, as well as the occurrence of liver tumors in the rat bioassay only at doses which exceeded the MTD and caused significant liver toxicity, repeated toxic insult followed by compensatory cell proliferation is favored as an underlying mechanism for the observed rat tumorigenic response."( Genotoxicity of trans-anethole in vitro.
Gorelick, NJ, 1995
)
0.29
"The objective of the present work was to evaluate the broadest toxic effect of some synthetic additives of colorants and/or flavors on different body organs and metabolic aspects in rats."( Toxic effects of some synthetic food colorants and/or flavor additives on male rats.
El-Wahab, HM; Moram, GS, 2013
)
0.39
" Based on 24-h LC50 values, binary mixtures of Bti and CA, AN, or EU were significantly more toxic against Ae."( Enhanced toxicity of binary mixtures of Bacillus thuringiensis subsp. israelensis and three essential oil major constituents to wild Anopheles sinensis (Diptera: Culicidae) and Aedes albopictus (Diptera: Culicidae).
Ahn, YJ; Chang, KS; Shin, EH; Yoo, DH, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
" Because there are some data about the impact of aniseed EO on drug effects, this survey aimed to assess the potential of pharmacokinetic herb-drug interaction between aniseed EO and acetaminophen and caffeine in mice."( Pharmacokinetic Herb-Drug Interaction between Essential Oil of Aniseed (Pimpinella anisum L., Apiaceae) and Acetaminophen and Caffeine: A Potential Risk for Clinical Practice.
Božin, B; Mijatović, V; Petković, S; Samojlik, I; Stilinović, N; Vukmirović, S, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study aimed to investigate the effects of anise essential oil alone and in combination with conventional antibiotics (amoxicillin, ciprofloxacin) against Streptococcus pneumoniae clinical isolates."( Screening of antibacterial effects of anise essential oil alone and in combination with conventional antibiotics against Streptococcus pneumoniae clinical isolates.
Aprotosoaie, AC; Brebu, M; Gradinaru, AC; Miron, A; Spac, A; Trifan, A,
)
0.13
"Herbal products containing anise essential oil may be used as expectorants in combination with amoxicillin or ciprofloxacin in Streptococcus pneumoniae infections without diminishing antibiotic efficacy."( Screening of antibacterial effects of anise essential oil alone and in combination with conventional antibiotics against Streptococcus pneumoniae clinical isolates.
Aprotosoaie, AC; Brebu, M; Gradinaru, AC; Miron, A; Spac, A; Trifan, A,
)
0.13

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of orally applied caffeine was also significantly decreased (p = 0."( Pharmacokinetic Herb-Drug Interaction between Essential Oil of Aniseed (Pimpinella anisum L., Apiaceae) and Acetaminophen and Caffeine: A Potential Risk for Clinical Practice.
Božin, B; Mijatović, V; Petković, S; Samojlik, I; Stilinović, N; Vukmirović, S, 2016
)
0.43
" With the enhanced bioavailability of TA, we aimed to determine its effect on osteogenesis; TA at different concentrations (5, 10, and 20 μM) was loaded onto polycaprolactone (PCL)/polyvinylpyrrolidone (PVP) fibers by the electrospinning technique."( Fabrication of PCL/PVP Electrospun Fibers loaded with Trans-anethole for Bone Regeneration in vitro.
Balagangadharan, K; Balaji, H; PranavKumar Shadamarshan, R; Rao, HS; Selvamurugan, N; Viji Chandran, S, 2018
)
0.48
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"The pharmacokinetic results indicate that XHX can significantly decrease the absorption and bioavailability and accelerate the elimination process of toosendanin in CLZ."( Determination of toosendanin and trans-anethole in Fructus Meliae Toosendan and Fructus Foeniculi by HPLC-MS/MS and GC-MS/MS in rat plasma and their potential herb-herb interactions.
Liu, L; Shi, L; Wang, Q; Xu, Y; Yu, J; Zhang, R; Zhang, T; Zhang, Y; Zhao, J, 2020
)
0.56
" These results indicated that treatment with SLMAN at a dose that was 5-10 times lower than non-encapsulated AN exerted an inhibitory effect on acute and chronic inflammatory responses, suggesting the better bioavailability and efficacy of microencapsulated AN without aggravating lesions in the gastric mucosa in arthritic rats."( Development and characterization of trans-anethole-containing solid lipid microparticles: antiinflammatory and gastroprotective effects in experimental inflammation.
Ames, FQ; Bersani-Amado, CA; Bonetti, CI; Bracht, L; Cardia, GFE; Cuman, RKN; da Rocha, EMT; Duda, JV; Gonçalves, OH; Leimann, FV; Schneider, LCL, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" They now report, however, that modulation of epoxide metabolism in cultured cells by the same mechanisms fails to induce unscheduled DNA synthesis (UDS) by anethole nor was there a UDS response in hepatocytes of female rats dosed with anethole in vivo."( Lack of influence of modulators of epoxide metabolism on the genotoxicity of trans-anethole in freshly isolated rat hepatocytes assessed with the unscheduled DNA synthesis assay.
Caldwell, J; Marshall, AD, 1996
)
0.29
" At the antithrombotic dosage they were free from prohemorrhagic side effect at variance with acetylsalicylic acid used as reference drug."( Protective effect of Foeniculum vulgare essential oil and anethole in an experimental model of thrombosis.
Ballabeni, V; Barocelli, E; Bertoni, S; Bruni, R; Impicciatore, M; Tognolini, M, 2007
)
0.34
" All test chemicals acted fast and showed a steep dose-response relationship."( Insecticidal activity of basil oil, trans-anethole, estragole, and linalool to adult fruit flies of Ceratitis capitata, Bactrocera dorsalis, and Bactrocera cucurbitae.
Chang, CL; Cho, IK; Li, QX, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (10 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care10

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Auromere Ayurvedic Herbal Toothpaste Cinnamon -- 3.57 ozAuromereBeauty & Personal Careanethol, catechu, glycerin, menthol, p thymol2024-11-29 10:47:42
Auromere Ayurvedic Herbal Toothpaste Classic -- 4.16 ozAuromereBeauty & Personal Careanethol, catechu, glycerin, menthol, pthymol, thymol2024-11-29 10:47:42
Auromere Ayurvedic Herbal Toothpaste Fresh Mint -- 4 ozAuromereBeauty & Personal Careanethol, catechu, glycerine, menthol, p Thymol, thymol2024-11-29 10:47:42
Auromere Ayurvedic Herbal Toothpaste in a Jar Fresh Mint -- 4.16 ozAuromereBeauty & Personal Careanethol, catechu, cellulose, glycerine, menthol, p thymol, thymol2024-11-29 10:47:42
Auromere Ayurvedic Herbal Toothpaste Mint Free Unflavored -- 4 ozAuromereBeauty & Personal Careanethol, catechu, cellulose, glycerine, p thymol, sodium lauryl sulfate2024-11-29 10:47:42
Eco-dent DailyCare Toothpowder Original Mint -- 2 ozEco-dentBeauty & Personal CareAnethole, Dicalcium Phosphate Dihydrate, Calcium Carbonate, Magnesium Carbonate, Menthol, Sodium Bicarbonate, Tartaric Acid2024-11-29 10:47:42
Eco-dent GentleFloss Premium Dental Floss Mint -- 100 YardsEco-dentBeauty & Personal Careorange, geranium, anethole, basil, menthol2024-11-29 10:47:42
Eco-dent Ultimate Daily Rinse Spicy Cool Cinnamon -- 8 fl ozEco-dentBeauty & Personal Careorange, geranium, anethole, CoQ10, golden seal, basil, menthol, stevia, baking soda, ubiquinone2024-11-29 10:47:42
Eco-dent Ultimate Essential MouthCare -- 8 fl ozEco-dentBeauty & Personal Careorange, geranium, anethole, CoQ10, golden seal, basil, glycerin, menthol, stevia, ubiquinone2024-11-29 10:47:42
Ola Botanicals Dental Floss 100% Vegan-Waxed Peppermint -- 100 YardsOla BotanicalsBeauty & Personal Careorange, anethole, basil, menthol2024-11-29 10:47:42

Roles (1)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
anetholeA monomethoxybenzene that is methoxybenzene substituted by a prop-1-en-1-yl group at position 4.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
t-anethole biosynthesis29
epoxypseudoisoeugenol-2-methylbutanoate biosynthesis016
t-anethole biosynthesis215
epoxypseudoisoeugenol-2-methylbutanoate biosynthesis222

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency35.48130.177814.390939.8107AID2147
RAR-related orphan receptor gammaMus musculus (house mouse)Potency5.29820.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency0.00130.000221.22318,912.5098AID743035
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency15.48710.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.39140.000214.376460.0339AID720691
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency49.59660.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency68.58960.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.45070.000229.305416,493.5996AID743075; AID743079
GVesicular stomatitis virusPotency7.76190.01238.964839.8107AID1645842
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.15820.001024.504861.6448AID743215
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency62.43840.000627.21521,122.0200AID743202
Interferon betaHomo sapiens (human)Potency7.76190.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency7.76190.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency7.76190.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency7.76190.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (45)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (22)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (92)

Assay IDTitleYearJournalArticle
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1063011Antimetastatic activity in human DU145 cells assessed as increase of E-cadherin mRNA expression at 25 to 100 uM by RT-PCR analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063015Antimigratory activity in human DU145 cells at 100 uM by wound-healing assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063006Antimetastatic activity in human DU145 cells assessed as decrease of MMP9 mRNA expression at 25 to 100 uM by RT-PCR analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1090222Antifungal activity against Zygosaccharomyces bailii assessed as growth inhibition measured at pH 5 after 48 hr by macrodilution assay2005Journal of agricultural and food chemistry, Jun-29, Volume: 53, Issue:13
Naturally occurring antifungal agents against Zygosaccharomyces bailii and their synergism.
AID1063005Inhibition of MMP9 in human DU145 cells after 24 hrs by SDS-PAGE gelatin zymography assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1062999Antimetastatic activity in human DU145 cells assessed as reduction of twist expression at 100 uM after 24 hrs by Western blotting in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1090221Antifungal activity against Zygosaccharomyces bailii assessed as growth inhibition measured at pH 7 after 48 hr by macrodilution assay2005Journal of agricultural and food chemistry, Jun-29, Volume: 53, Issue:13
Naturally occurring antifungal agents against Zygosaccharomyces bailii and their synergism.
AID1103166Drug excretion in 80 last instar Trichoplusia ni (cabbage looper) larvae feces assessed as unchanged parent compound at 0.1 % fwt, po measured after 3 days by 1H/13C NMR analysis2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Metabolism of thymol and trans-anethole in larvae of Spodoptera litura and Trichoplusia ni (Lepidoptera: Noctuidae).
AID334997Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1090223Antifungal activity against Zygosaccharomyces bailii assessed as growth inhibition measured at pH 3 after 48 hr by macrodilution assay2005Journal of agricultural and food chemistry, Jun-29, Volume: 53, Issue:13
Naturally occurring antifungal agents against Zygosaccharomyces bailii and their synergism.
AID1063007Antimetastatic activity in human DU145 cells assessed as decrease of PI3K/Akt expression by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1062997Antimetastatic activity in human DU145 cells assessed as increase of E-cadherin expression at 100 uM after 24 hrs by immunofluorescence analysis in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1103162Drug excretion in 80 last instar Trichoplusia ni (cabbage looper) larvae feces assessed as side chain methyl group hydroxylated compound on at 0.1 % fwt, po by TLC analysis2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Metabolism of thymol and trans-anethole in larvae of Spodoptera litura and Trichoplusia ni (Lepidoptera: Noctuidae).
AID334996Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1090229Antifungal activity against Zygosaccharomyces bailii assessed as growth inhibition measured after 48 hr by macrodilution assay2005Journal of agricultural and food chemistry, Jun-29, Volume: 53, Issue:13
Naturally occurring antifungal agents against Zygosaccharomyces bailii and their synergism.
AID1063000Antimetastatic activity in human DU145 cells assessed as increase of E-cadherin expression at 100 uM after 24 hrs by Western blotting in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063013Antimetastatic activity in human DU145 cells assessed as decrease of vimentin expression at 25 to 100 uM by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1090220Antifungal activity against Zygosaccharomyces bailii assessed as growth inhibition measured at pH 9 after 48 hr by macrodilution assay2005Journal of agricultural and food chemistry, Jun-29, Volume: 53, Issue:13
Naturally occurring antifungal agents against Zygosaccharomyces bailii and their synergism.
AID1063001Antiinvasive activity in human DU145 cells assessed as reduction of number of invaded cells through matrigel at 100 uM after 8 hrs by Boyden chamber invasion assay in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID334995Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1063014Antimetastatic activity in human DU145 cells assessed as increase of E-cadherin expression at 25 to 100 uM by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID334993Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1081538Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 24 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID1063016Antiinvasive activity in human DU145 cells assessed as reduction of number of invaded cells through matrigel at 25 to 100 uM after 8 hrs by Boyden chamber invasion assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063010Antimetastatic activity in human DU145 cells assessed as decrease of vimentin mRNA expression at 25 to 100 uM by RT-PCR analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID337836Antifungal activity against Candida albicans ATCC 18804 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID334998Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID335000Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1063002Antimetastatic activity in human DU145 cells assessed as decrease of MMP9 expression at 100 uM in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID334994Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1063009Antimetastatic activity in human DU145 cells assessed as decrease of twist mRNA expression at 25 to 100 uM by RT-PCR analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1062998Antimetastatic activity in human DU145 cells assessed as reduction of vimentin expression at 100 uM after 24 hrs by Western blotting in presence of TGF-beta2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063018Cytotoxicity against human DU145 cells assessed as cell viability up to 200 uM after 24 hrs by MTT assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063008Antimetastatic activity in human DU145 cells assessed as decrease of snail mRNA expression at 25 to 100 uM by RT-PCR analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1063017Inhibition of cell adhesion in human DU145 cells in vitronectin-coated plates at 25 to 100 uM2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1103165Drug excretion in 80 last instar Trichoplusia ni (cabbage looper) larvae feces assessed as side chain methyl group hydroxylated compound on at 0.1 % fwt, po by 1H/13C NMR analysis2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Metabolism of thymol and trans-anethole in larvae of Spodoptera litura and Trichoplusia ni (Lepidoptera: Noctuidae).
AID334989Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1081539Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID334990Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1439508Antihelmintic activity against larval stage of Haemonchus contortus2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1439507Antihelmintic activity against egg stage of Haemonchus contortus2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1081540Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 96 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID348953Antibacterial activity against Escherichia coli ATCC 9637 up to 200 ug/ml after 2 days by twofold broth dilution method2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Design and evaluation of anacardic acid derivatives as anticavity agents.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID334991Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID337835Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1063003Antimetastatic activity in MMP9 siRNA transfected human DU145 cells assessed as increase of vimentin expression at 25 to 100 uM by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID1103161Drug excretion in 80 last instar Spodoptera litura larvae feces assessed as side chain methyl group hydroxylated compound on at 0.1 % fwt, po by TLC analysis2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Metabolism of thymol and trans-anethole in larvae of Spodoptera litura and Trichoplusia ni (Lepidoptera: Noctuidae).
AID334999Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1063012Antimetastatic activity in human DU145 cells assessed as decrease of twist expression at 25 to 100 uM by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID334992Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID337837Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1063004Antimetastatic activity in MMP9 siRNA transfected human DU145 cells assessed as increase of E-cadherin expression at 25 to 100 uM by Western blotting2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (302)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (8.94)18.7374
1990's25 (8.28)18.2507
2000's54 (17.88)29.6817
2010's127 (42.05)24.3611
2020's69 (22.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (1.60%)5.53%
Reviews8 (2.56%)6.00%
Case Studies6 (1.92%)4.05%
Observational1 (0.32%)0.25%
Other292 (93.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]